Electroencephalography (EEG) Devices Market Size, Share, Trends, & Industry Analysis Report
By Product (8-channel EEG, 21-channel EEG, 25-channel EEG, 32-channel EEG, 40-channel EEG, and Multichannel EEG), By Modality, By Application, By End Use, and By Region – Market Forecast, 2025–2034
- Published Date:Sep-2025
- Pages: 125
- Format: PDF
- Report ID: PM1833
- Base Year: 2024
- Historical Data: 2020-2023
Overview
The global electroencephalography devices market size was valued at USD 1,414.25 million in 2024, growing at a CAGR of 9.5% from 2025 to 2034. Key factors drivingElectroencephalography (EEG) Devices Market demand for electroencephalography (EEG) devices include increasing healthcare spending, growing aging population, and rising incidence of Alzheimer’s disease.
Key Insights
- The 32-channel EEG segment accounted for 26.08% of revenue share in 2024 due to growing prevalence of neurological disorders.
- The standalone systems segment held 77.73% of revenue share in 2024, due to their ability to offer high accuracy, stability, and advanced data processing capabilities.
- North America electroencephalography devices market held 36.43% of the global electroencephalography devices market share in 2024, owing to the increasing prevalence of neurological disorders such as epilepsy, Alzheimer’s disease, and sleep disorders.
- U.S. held 75.76% of revenue share in the North America electroencephalography (EEG) devices landscape in 2024, due to the high incidence of epilepsy and other seizure disorders.
- The industry in Europe is projected to grow at a CAGR of 9.3% from 2025 to 2034, owing to developed healthcare systems.
Industry Dynamics
- Increasing healthcare spending across the globe is driving the demand for electroencephalography (EEG) devices by encouraging hospitals and clinics to purchase these devices for detecting epilepsy, sleep disorders, brain injuries, and other neurological conditions.
- Growing aging population is propelling the demand for electroencephalography (EEG) devices, as older adults witness higher rates of sleep disorders, cognitive decline, and age-related brain injuries, all of which necessitate frequent neurological assessments through EEG devices.
- Advancements in EEG technology are creating a lucrative market opportunity.
- Poor spatial resolution of electroencephalography (EEG) devices may hamper the industry growth.
AI Impact on Electroencephalography (EEG) Devices Market
- Artificial intelligence enhances EEG data analysis, enabling faster, more accurate detection of neurological disorders like epilepsy.
- Machine learning algorithms improve pattern recognition, reducing false positives and increasing diagnostic precision.
- AI-powered portable EEG devices enable real-time monitoring and remote patient care.
- Integration of AI accelerates brain-computer interface (BCI) development for assistive and consumer technologies.
Market Statistics
- 2024 Market Size: USD 1,414.25 Million
- 2034 Projected Market Size: USD 3,492.03 Million
- CAGR (2025-2034): 9.5%
- North America: Largest Market Share
Electroencephalography (EEG) devices are medical instruments designed to record the brain’s electrical activity through electrodes placed on the scalp. These devices detect voltage fluctuations resulting from ionic currents within neurons, allowing clinicians and researchers to analyze brain wave patterns in real time. EEG devices play a crucial role in diagnosing neurological disorders such as epilepsy, sleep disorders, brain injuries, and dementia by providing valuable insights into abnormal brain activity.
They are also widely used in monitoring patients under anesthesia, assessing brain function in intensive care units, and evaluating the effectiveness of neurological treatments. EEG devices are gaining importance in cognitive neuroscience, brain-computer interface (BCI) research, and mental health monitoring. Portable and wearable EEG systems have expanded their usage into home healthcare, enabling continuous brain activity tracking for early detection of conditions and personalized treatment. The technology offers a non-invasive, cost-effective, and highly reliable method for brain monitoring, making it crucial in both medical and research settings while also supporting innovations in neurotechnology and human-computer interaction.
-devices-market-size,-by-region,-2020---2034.webp)
The global demand for electroencephalography (EEG) devices is driven by the rising incidence of Alzheimer’s disease. According to the Alzheimer's Association, over 7 million Americans are living with Alzheimer's, and by 2050, this number is projected to rise to nearly 13 million. This is driving hospitals and medical agencies across the globe to invest in EEG devices, as they help clinicians detect Alzheimer’s by measuring electrical activity in the brain. Furthermore, the ongoing research is highlighting the potential of EEG in identifying biomarkers associated with Alzheimer’s, which is encouraging wider adoption of these devices in both clinical and research settings. Therefore, the rising incidence of Alzheimer’s disease globally is fueling the adoption of EEG devices.
Drivers & Opportunities/Trends
Increasing Healthcare Spending: Rising healthcare spending is driving hospitals and clinics to purchase EEG devices, which are essential for detecting epilepsy, sleep disorders, brain injuries, and other neurological conditions. According to the American Medical Association, health spending in the U.S. increased by 7.5% in 2023. Higher healthcare spending is also supporting specialized training for neurologists and technicians, increasing the capacity to perform EEG tests. Additionally, expanded insurance coverage and public health programs, driven by rising healthcare spending, are making neurological evaluations more affordable and accessible to patients, leading to a rising adoption of EEG devices.
Growing Aging Population: Older adults have a higher risk of developing neurological disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and stroke. These conditions often require regular brain activity monitoring, diagnosis, and management, which EEG devices provide with precision and non-invasive technology. Older adults also witness higher rates of sleep disorders, cognitive decline, and age-related brain injuries, all of which necessitate frequent neurological assessments through EEG devices. Governments and healthcare systems in many countries are expanding their focus on geriatric care, investing in advanced diagnostic tools such as EEG devices to improve patient outcomes and reduce long-term healthcare costs. Hence, the growing aging population across the globe is propelling the demand for EEG devices. For instance, according to the World Health Organization, the number of people aged 60 and older worldwide is projected to increase from 1.1 billion in 2023 to 1.4 billion by 2030.
-devices-market-size-worth-usd-3,492.03-million-by-2034.webp)
Segmental Insights
Product Analysis
Based on product, the segmentation includes 8-channel EEG, 21-channel EEG, 25-channel EEG, 32-channel EEG, 40-channel EEG, and multichannel EEG. The 32-channel EEG segment accounted for 26.08% of revenue share in 2024 due to growing prevalence of neurological disorders, such as epilepsy, Alzheimer’s disease, and sleep disorders. These devices delivered a strong balance between data accuracy and cost-effectiveness, making them highly suitable for routine hospital use and advanced academic studies. Neurologists preferred 32-channel setups since they provided high-resolution brain activity mapping without the complexity and higher expense of multichannel systems.
The 40-channel EEG segment is projected to grow at a CAGR of 11.6% from 2025 to 2034, owing to its ability to provide detailed brain wave analysis and advanced functional mapping. Research institutions and specialized hospitals are increasingly choosing these systems for complex studies on brain connectivity and cognitive functions. The rising demand for precision in diagnosing rare neurological conditions, along with technological advancements in portable and wireless monitoring solutions, is fueling the segment’s expansion.
Modality Analysis
Based on modality, the segmentation includes standalone systems and portable systems. The standalone systems segment held 77.73% of revenue share in 2024 as hospitals and specialized neurology centers relied on them for routine diagnostics and long-term monitoring. These systems offered high accuracy, stability, and advanced data processing capabilities, which made them ideal for detecting complex neurological conditions such as epilepsy, dementia, and traumatic brain injuries. Healthcare professionals preferred standalone systems since they allowed comprehensive brain activity analysis and integrated seamlessly with hospital infrastructure. The increasing patient volume in clinical settings and the growing need for reliable diagnostic equipment strengthened the dominance of the segment.
Application Analysis
In terms of application, the segmentation includes trauma & surgery, disease diagnosis, anesthesia monitoring, and sleep monitoring. The disease diagnosis segment accounted for 43.13% of revenue share in 2024 due to the rising global burden of neurological conditions, coupled with the growing need for non-invasive and cost-efficient diagnostic tools. Clinicians increasingly relied on EEG systems to identify and monitor neurological disorders such as epilepsy, Parkinson’s disease, Alzheimer’s disease, and brain tumors. Additionally, advancements in software integration and data analytics enhanced the diagnostic value of EEG tests, making them crucial in disease diagnosis.
End Use Analysis
Based on end use, the segmentation includes hospitals, diagnostic centers, and others. The hospitals segment was valued at USD 929.0 million in 2024, as they served as the primary centers for neurological care, advanced diagnostics, and surgical procedures requiring EEG monitoring. Physicians in hospitals relied on these systems to manage a wide range of conditions, including epilepsy, traumatic brain injuries, and neurodegenerative diseases. The presence of equipped infrastructure, skilled professionals, and higher patient inflow strengthened hospital dominance. Moreover, hospitals invested heavily in advanced EEG technologies to support both routine clinical evaluations and complex neurosurgical interventions, which further expanded their revenue share.
The diagnostic centers segment is projected to grow at a CAGR of 10.7% from 2025 to 2034, owing to rising awareness of early diagnosis. Patients are increasingly preferring these centers for faster service delivery, lower costs compared to hospitals, and greater accessibility in urban as well as semi-urban areas. Diagnostic centers also expanded their adoption of portable and digital EEG systems, which allow for quicker turnaround times and integration with telemedicine platforms. The rising incidence of neurological disorders and the shift toward outpatient care models is encouraging wider use of EEG in diagnostic centers.
-devices-market-by-component-analysis,-2020---2034.webp)
Regional Analysis
North America electroencephalography (EEG) devices market held 36.43% of global EEG devices market share in 2024. This dominance is attributed to the increasing prevalence of neurological disorders such as epilepsy, Alzheimer’s disease, and sleep disorders, coupled with a growing aging population. The number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050. The region also benefited from advanced healthcare infrastructure, high healthcare expenditure, and strong research and development activities in neuroscience and neurotechnology. Government initiatives and funding for neurological research, along with favorable reimbursement policies in countries such as the U.S. and Canada, further supported market growth. The presence of key players and a high level of awareness among healthcare professionals also contributed to the expanding use of EEG devices in the region.
U.S. Electroencephalography Devices Market Insight
U.S. held 75.76% of revenue share in the North America electroencephalography (EEG) devices landscape in 2024, due to high incidence of epilepsy and other seizure disorders, increasing diagnosis rates, and widespread adoption of advanced diagnostic technologies. According to the Centers for Disease Control and Prevention, during 2021 and 2022, about 2.9 million US adults 18 and older reported having active epilepsy. Hospitals, academic research institutions, and ambulatory care centers in the country increasingly adopted ambulatory EEG systems for improved patient monitoring and diagnostics. Favorable regulatory pathways by the FDA for novel EEG devices, combined with established reimbursement mechanisms, encouraged market penetration. Moreover, growing consumer interest in wearable and portable EEG devices for mental wellness and cognitive performance tracking created new commercial opportunities.
Asia Pacific Electroencephalography (EEG) Devices Market
The Asia Pacific market is projected to hold a significant revenue share in 2034, driven by improving healthcare infrastructure, rising awareness about neurological conditions, and increasing healthcare spending in emerging economies. Countries such as India, Japan, and South Korea are investing heavily in neurology research and hospital modernization, driving demand for EEG devices. The growing burden of stroke, epilepsy, and neurodegenerative diseases, along with a large and aging population, is further amplifying the need for EEG monitoring. Government support for digital health and telemedicine, especially in rural areas, is facilitating the adoption of portable and wireless EEG systems. Additionally, expanding medical tourism and increasing collaborations between local and international manufacturers are contributing to industry expansion.
China Electroencephalography Devices Market Overview
The demand for electroencephalography (EEG) devices in China is being driven by government initiatives to modernize healthcare infrastructure, rising prevalence of neurological disorders due to an aging population, and increasing public awareness of brain health. The Chinese government’s focus on advancing medical technology and reducing reliance on imported equipment has led to growth in domestic production and innovation of EEG systems. Urban hospitals are adopting advanced EEG solutions for neurocritical care and epilepsy monitoring. Furthermore, growing research in neuroscience and collaborations with international institutions are fostering technological advancements. Rising healthcare expenditure and improvements in insurance coverage are also making EEG diagnostics more accessible in the country.
Europe Electroencephalography (EEG) Devices Market
The industry in Europe is projected to grow at a CAGR of 9.3% from 2025 to 2034, owing to developed healthcare systems, strong emphasis on neurological research, and comprehensive public health policies. Countries such as Germany, the UK, France, and Sweden have high adoption rates of EEG technologies in both clinical and research settings. The increasing incidence of epilepsy, dementia, and sleep disorders, combined with robust screening and diagnostic protocols, is driving the need for reliable EEG monitoring. The European Union is funding numerous neuroscience projects through programs like Horizon Europe, encouraging innovation in EEG-based diagnostics and brain-computer interfaces. Stringent regulatory standards are ensuring device safety and efficacy, while national reimbursement schemes are supporting clinical use.
-devices-market-trends,-by-region,-2020-–-2034.webp)
Key Players & Competitive Analysis Report
The electroencephalography devices market is highly competitive, characterized by a diverse mix of established medical technology firms and innovative startups driving advancements in both clinical and consumer applications. Key players, including Brain Products GmbH, Compumedics Neuroscan, and Electrical Geodesics Inc., dominate the clinical and research segments with high-density, FDA-approved systems renowned for their accuracy and reliability. Meanwhile, companies like ANT Neuro and BioSemi offer specialized, high-resolution EEG solutions tailored for neuroscience research and diagnostic applications. On the consumer and wearable front, Emotiv, NeuroSky, and Muse have gained traction with affordable, portable EEG headsets aimed at wellness, neurofeedback, and brain-computer interface (BCI) applications. OpenBCI and Neuroelectrics are pushing innovation in open-source and non-invasive neuromodulation technologies, fostering developer engagement and personalized brain monitoring. The market is further shaped by technological convergence, miniaturization, and AI integration, enabling real-time data analysis and broader accessibility. Companies are increasingly focusing on hybrid models that bridge clinical validity with user-friendly design, intensifying competition and accelerating product differentiation across segments.
Major companies operating in the electroencephalography (EEG) devices industry include Advanced Brain Monitoring, Inc.; ANT Neuro; BioSemi; BioSerenity, Inc.; Brain Products GmbH; Compumedics Neuroscan; Electrical Geodesics Inc.; Emotiv; Muse; Neuroelectrics; NeuroSky; OpenBCI; Soterix Medical Inc.
Key Companies
- Advanced Brain Monitoring, Inc.
- ANT Neuro
- BioSemi
- BioSerenity, Inc.
- Brain Products GmbH
- Compumedics Neuroscan
- Electrical Geodesics Inc.
- Emotiv
- Muse
- Neuroelectrics
- NeuroSky
- OpenBCI
- Soterix Medical Inc.
Industry Developments
April 2024, Soterix Medical Inc., announced the launch of MxN-GO EEG, a combined high definition transcranial electrical stimulation (HD-tES) and EEG system with a unique untethered design.
January 2021, BioSerenity, Inc. announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Neuronaute EEG System and IceCap EEG wearable device that will allow physicians to remotely monitor and assess the electrical brain activity of people living with epilepsy.
Electroencephalography (EEG) Devices Market Segmentation
By Product Outlook (Revenue, USD Million, 2020–2034)
- 8-channel EEG
- 21-channel EEG
- 25-channel EEG
- 32-channel EEG
- 40-channel EEG
- Multichannel EEG
By Modality Outlook (Revenue, USD Million, 2020–2034)
- Standalone Systems
- Portable Systems
By Application Outlook (Revenue, USD Million, 2020–2034)
- Trauma & Surgery
- Disease Diagnosis
- Anesthesia Monitoring
- Sleep Monitoring
By End Use Outlook (Revenue, USD Million, 2020–2034)
- Hospitals
- Diagnostic Centers
- Others
By Regional Outlook (Revenue, USD Million, 2020–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Electroencephalography (EEG) Devices Market Report Scope
|
Report Attributes |
Details |
|
Market Size in 2024 |
USD 1,414.25 Million |
|
Market Size in 2025 |
USD 1,545.49 Million |
|
Revenue Forecast by 2034 |
USD 3,492.03 Million |
|
CAGR |
9.5% from 2025 to 2034 |
|
Base Year |
2024 |
|
Historical Data |
2020–2023 |
|
Forecast Period |
2025–2034 |
|
Quantitative Units |
Revenue in USD Million and CAGR from 2025 to 2034 |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Industry Trends |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
FAQ's
The global market size was valued at USD 1,414.25 million in 2024 and is projected to grow to USD 3,492.03 million by 2034.
The global market is projected to register a CAGR of 9.5% during the forecast period.
North America dominated the market in 2024
A few of the key players in the market are Advanced Brain Monitoring, Inc.; ANT Neuro; BioSemi; BioSerenity, Inc.; Brain Products GmbH; Compumedics Neuroscan; Electrical Geodesics Inc.; Emotiv; Muse; Neuroelectrics; NeuroSky; OpenBCI; Soterix Medical Inc.
The 40-channel EEG segment dominated the market revenue share in 2024.
The diagnostic centers segment is projected to witness the fastest growth during the forecast period.
© 2025 Polaris Market Research and Consulting. All rights reserved
